Literature DB >> 3741909

Effects of depression and ECT on anterograde memory.

B L Steif, H A Sackeim, S Portnoy, P Decina, S Malitz.   

Abstract

This study investigated immediate and delayed recognition memory in depressed patients undergoing electroconvulsive therapy (ECT) and in matched, normal controls. At baseline, patients manifested a marked deficit in immediate memory (acquisition), but showed no deficit in delayed memory (retention). When retested 24-36 hr following the seventh ECT, patients showed reductions in both immediate and delayed memory performance. At retesting 4 days, on average, after the ECT course, immediate memory scores returned to baseline levels, but delayed memory performance remained impaired. The findings supported the classic claims that depression is associated with a deficit in the acquisition of information, whereas ECT has a more profound influence on the retention of information. This dissociative pattern could not be viewed as an artifact of task psychometric properties, nor of practice effects in control subjects.

Entities:  

Mesh:

Year:  1986        PMID: 3741909     DOI: 10.1016/0006-3223(86)90266-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

Review 1.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

2.  Auditory processing of sine tones before, during and after ECT in depressed patients by fMRI.

Authors:  Martin Christ; Nikolaus Michael; Hermina Hihn; Anne Schüttke; Carsten Konrad; Bernhard T Baune; Andreas Jansen; Bettina Pfleiderer
Journal:  J Neural Transm (Vienna)       Date:  2008-03-04       Impact factor: 3.575

3.  Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology.

Authors:  Zafiris J Daskalakis; Shawn M McClintock; Itay Hadas; Elisa Kallioniemi; Reza Zomorrodi; Alanah Throop; Lucy Palmer; Faranak Farzan; Kevin E Thorpe; Carol Tamminga; Daniel M Blumberger
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

4.  Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.

Authors:  Zafiris J Daskalakis; Carol Tamminga; Alanah Throop; Lucy Palmer; Julia Dimitrova; Faranak Farzan; Kevin E Thorpe; Shawn M McClintock; Daniel M Blumberger
Journal:  Trials       Date:  2021-11-08       Impact factor: 2.279

Review 5.  Cognitive effects of rapid-acting treatments for resistant depression: Just adverse, or contributing to clinical efficacy?

Authors:  Salvador M Guinjoan; Karl-Jürgen Bär; Joan A Camprodon
Journal:  J Psychiatr Res       Date:  2021-06-15       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.